相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
Chin-Chou Huang et al.
SCIENTIFIC REPORTS (2020)
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites
Sherif M. Shoieb et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states
Sherif M. Shoieb et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice
Y. Kapelyukh et al.
DRUG METABOLISM AND DISPOSITION (2019)
19-Hydroxyeicosatetraenoic acid analogs: Antagonism of 20-hydroxyeicosatetraenoic acid-induced vascular sensitization and hypertension
Rambabu Dakarapu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Identification of 19-(S/R)Hydroxyeicosatetraenoic Acid as the First Endogenous Noncompetitive Inhibitor of Cytochrome P450 1B1 with Enantioselective Activity
Sherif M. Shoieb et al.
DRUG METABOLISM AND DISPOSITION (2019)
Role of oxylipins in cardiovascular diseases
Mohammed A. Nayeem
ACTA PHARMACOLOGICA SINICA (2018)
S-Enantiomer of 19-Hydroxyeicosatetraenoic Acid Preferentially Protects Against Angiotensin II-Induced Cardiac Hypertrophy
Sherif M. Shoieb et al.
DRUG METABOLISM AND DISPOSITION (2018)
Modulation of CYP1A1 metabolism: From adverse health effects to chemoprevention and therapeutic options
Melina Mescher et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity
Kristyna Krasulova et al.
MOLECULES (2017)
Potential role of CYP1B1 in the development and treatment of metabolic diseases
Fei Li et al.
PHARMACOLOGY & THERAPEUTICS (2017)
The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p
Yinting Chen et al.
BIOCHEMICAL PHARMACOLOGY (2017)
CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism
Zaid H. Maayah et al.
PHARMACOLOGICAL RESEARCH (2016)
Development of an In Vitro Model to Screen CYP1B1-Targeted Anticancer Prodrugs
Zhiying Wang et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Diversity and evolution of cytochrome P450 monooxygenases in Oomycetes
Mopeli Marshal Sello et al.
SCIENTIFIC REPORTS (2015)
Role of the modulation of CYP1A1 expression and activity in chemoprevention
S. Badal et al.
JOURNAL OF APPLIED TOXICOLOGY (2014)
The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China
Jin-Guo Zou et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism
Agnes A. Walsh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Contributions of the Three CYP1 Monooxygenases to Pro-Inflammatory and Inflammation-Resolution Lipid Mediator Pathways
Senad Divanovic et al.
JOURNAL OF IMMUNOLOGY (2013)
Pyranoflavones: A Group of Small-Molecule Probes for Exploring the Active Site Cavities of Cytochrome P450 Enzymes 1A1, 1A2, and 1B1
Jiawang Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Cytochrome P450 Family 1 Inhibitors and Structure-Activity Relationships
Jiawang Liu et al.
MOLECULES (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis
Theodoros N. Sergentanis et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Analysis of Human CYP1A1 and CYP1A2 Genes and Their Shared Bidirectional Promoter in Eight World Populations
Lucia F. Jorge-Nebert et al.
HUMAN MUTATION (2010)
Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin
Thomas K. H. Chang et al.
JOURNAL OF PINEAL RESEARCH (2010)
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention
Vasilis P. Androutsopoulos et al.
BMC CANCER (2009)
EROD and MROD as Markers of Cytochrome P450 1A Activities in Hepatic Microsomes from Entire and Castrated Male Pigs
Galia Zamaratskaia et al.
SENSORS (2009)
Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction
MC Cornelis et al.
JOURNAL OF MEDICAL GENETICS (2004)
Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P4501B1
D Choudhary et al.
DRUG METABOLISM AND DISPOSITION (2004)
Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding
D Kim et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer
DW Nebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study
CC Hong et al.
BREAST CANCER RESEARCH (2004)
Summary of information on human CYP enzymes: Human P450 metabolism data
S Rendic
DRUG METABOLISM REVIEWS (2002)
分享论文
